[ORGANIZATION]
centanafadine
Featured in 1 tracked story · first seen
Situations
FDA approval of Simtriyo for ADHD treatment
2 clusters · 2 sources · last updated
Latest: FDA approves Simtriyo for adult and pediatric ADHD treatment
The U.S. Food and Drug Administration has approved Otsuka Pharmaceutical’s Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients aged six years and